Dr. Parastoo B. Dahi

Dr. Parastoo B. Dahi, MD, MS, is a board-certified hematologist and medical oncologist specializing in stem cell transplantation and cellular therapies at Memorial Sloan Kettering Cancer Center (MSK). Her clinical expertise encompasses chimeric antigen receptor (CAR) T-cell therapy, viral-specific T-cells (VSTs), and transplant-based treatments for adult patients with lymphoma, lymphoid leukemia, multiple myeloma, and refractory viral-associated infections or lymphoproliferative diseases. Fluent in both English and Persian (Farsi), she is deeply committed to providing compassionate, patient- and family-centered care throughout what can be a challenging and stressful treatment journey.

Dr. Dahi's clinical research focuses on improving transplant outcomes through personalized and targeted approaches designed to reduce the side effects and complications associated with stem cell transplantation and cellular therapies. Her work reflects a dedication to refining treatment strategies that balance efficacy with quality of life for patients undergoing complex therapies. She chairs both the Adult and Pediatric FACT Taskforce at MSK and the MSK Transplant Guideline Taskforce, and she serves as a member of the MSK BMT Quality Assurance Committee. These leadership roles underscore her commitment to institutional excellence and the continuous improvement of transplant protocols.

On a national level, Dr. Dahi serves as an inspector for FACT (Foundation for the Accreditation of Cellular Therapy), an internationally recognized body that accredits hospitals and medical centers offering stem cell transplantation and cellular therapy. FACT accreditation represents the highest standard of quality in the field, ensuring that clinical, apheresis, and processing facilities meet rigorous benchmarks across all aspects of care. Through her combined roles in research, quality assurance, and national accreditation, Dr. Dahi plays a meaningful part in shaping standards for transplant and cellular therapy both at MSK and across the broader medical community.